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Abstract
Host recognition of mycobacterial surface molecules occurs through toll like receptors (TLR) 2 and 6. The adaptor protein
TIRAP mediates down stream signalling of TLR2 and 4, and polymorphisms in the TIRAP gene (TIRAP) have been associated
with susceptibility and resistance to tuberculosis (TB) in adults. In order to investigate the role of polymorphic variation in
TIRAP in childhood TB in South Africa, which has one of the highest TB incidence rates in the world, we screened the entire
open reading frame of TIRAP for sequence variation in two cohorts of childhood TB from different ethnic groups (Xhosa and
mixed ancestry). We identified 13 SNPs, including seven previously unreported, in the two cohorts, and found significant
differences in frequency of the variants between the two ethnic groups. No differences in frequency between individual
SNPs or combinations were found between TB cases and controls in either cohort. However the 558CRT SNP previously
associated with TB meningitis (TBM) in a Vietnamese population was found to be associated with TBM in the mixed ancestry
group. Polymorphisms in TIRAP do not appear to be involved in childhood TB susceptibility in South Africa, but may play a
role in determining occurrence of TBM.
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Introduction
Activation of host inflammatory responses are fundamental to
containment of Mycobacterium tuberculosis (MTB) following initial
infection [1]. The majority of individuals who are exposed to MTB
successfully contain the infection and remain asymptomatic but
latently infected throughout life. TB disease develops in a minority
of those infected, either following the primary infection or due to
reactivation of latent disease many years later [2]. Differences in
immune response genes are believed to be important in
determining whether an individual successfully contains the
infection or develops disease [3,4,5], but the genes responsible
remain largely unknown.
Children not only have an increased risk of developing
progressive disease following exposure [6], but have a much
greater risk of developing disseminated forms of the disease
including TBM [7,8]. The ability to rapidly activate innate
immune responses is likely to be critical in the containment of
mycobacteria during primary infection in childhood, as evidenced
by the unique susceptibility to mycobacteria in patients with
Mendelian defects in interferon gamma (IFNc) and interleukin 12
(IL-12) pathways [9,10,11,12].
Innate immune recognition of mycobacterial surface molecules
including lipoarabinomannan, are believed to occur predominant-
ly through toll-like receptor (TLR) 2 [13] with TLR6 as its co
receptor [14], and possibly TLR4 [15]. Binding of the ligand
initiates a signalling cascade leading to activation of proinflamma-
tory responses [16]. The TIR-domain-containing adapter like
protein (TIRAP) is a cytoplasmic protein which is 221 amino acids
in length and is important in both the TLR2 and TLR4 mediated
signalling pathways [17,18]. Binding of the ligand to either
receptor leads to the recruitment of several molecules to the
receptor including the TIR-domain-containing adaptor molecules
such as the myeloid differentiation primary response gene 88
(MyD88) and TIRAP [18]. This complex recruits other molecules
including IL-1R kinases 1, 2, 3 and 4 (IRAK1, 2, 3 and 4) and
TNF receptor associated factor 6 (TRAF6) [19] which dissociate
and bind a further complex that consists of transforming growth
factor-b-activated kinase 1 (TAK1) and TAK-1-binding proteins
1, 2 and 3 (TAB 1, 2, 3). TAK1 activates the inhibitor of NFkB
kinase (IKK) via IKKc (also called NEMO). IKK causes the
phosphorylation of the inhibitor of NFkB( I kB), which leads to its
degradation and thereby allows NFkB to translocate to the nucleus
and promote the transcription of proinflammatory genes.
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6698Recent studies on the TIRAP gene have indicated that it may
play an important role in susceptibility to infectious diseases. The
single nucleotide polymorphism (SNP) 539CRT (S180L) has been
associated with protection against several infectious diseases
including pneumococcal disease, malaria and TB in Caucasian,
African and South American cohorts [20,21]. This result was not
replicated in a subsequent study on different European and African
groups [22]. In a Vietnamese cohort a synonymous SNP 558CRT
(A186A) was associated with TB meningitis in adults and also with
functional impairment of IL-6 production in vitro [23].
While these studies suggest that variation in TIRAP is potentially
important in determining susceptibility to TB and other infections,
the inconsistent findings between published data and the different
SNPs implicated in each, results in continued uncertainty as to its role
in influencing disease occurrence and outcome. One of the reasons
for this might be due to the ethnic differences in the groups studied.
The majority of studies have focused on the S180L polymorphism
t h a tw a sf i r s ti m p l i c a t e di naC a u c a s i a nc o h o r tw i t hi n v a s i v e
pneumococcal disease. This polymorphism has a much lower
frequency in African populations. Similarly, the A186A SNP,
associated with TB meningitis in the Vietnamese population, was
not studied in relation to clinical phenotype in the African population.
We set out to investigate the role of sequence variation in TIRAP
in children from two ethnic groups from South Africa, an area
with one of the highest TB incidence rates in the world [6,24]. We
reasoned that genetic differences in the innate immune response
would be more important in childhood TB where the inability to
contain the organism following initial infection is the usual
mechanism of disease. In order to detect not only previously
known variants, but also any novel polymorphisms or mutations,
we screened the entire open reading frame of the TIRAP for
sequence variation in cases with childhood TB and healthy
controls. In order to understand ethnic differences we studied
individuals from both the Xhosa populations and those with mixed
ancestry.
Results
Polymorphic variation in Xhosa and mixed ancestry
groups
We identified thirteen SNPs across the TIRAP gene of which
only seven have previously been identified. Two SNPs, the
303CRT and 427CRT were only seen in the Xhosa population
and were not found in the smaller mixed ancestry group (Table 1).
The minor allele frequency (MAF) of the majority of SNPs was
low (,0.05) with only 760ARG and 820CRT having a higher
frequency in both groups and the 558CRT in the mixed ancestry
group only (table 1). Three SNPs were significantly different
between the two groups. Two of these, the 539CRT (S180L) and
558CRT have been associated with TB disease in previous studies
in different ethnic groups [20,23]. The 820TRC SNP has almost
equal allele frequencies in the Xhosa group but the T allele was
present in 80% of the mixed ancestry group. The frequency in the
Xhosa is similar to frequencies of this SNP found in the PGA
African panel of African Americans, whereas that in the mixed
ancestry group was similar to the frequency in the PGA European
panel as published in the NCBI database (ss8820536) [25]. The
CC genotype was not seen in any of the mixed ancestry subjects
although it was prevalent in 20% and 30% of the Xhosa cases and
controls respectively.
Only five of the 11 SNPs identified in the mixed ancestry TB
cases were also found in the controls. However as the number of
controls was small and as these alleles were at low frequency this
result may be due to sample size differences alone.
Case Control study
Having identified SNPs in the coding region in each ethnic
group, we next sought to identify any association between
individual TIRAP variants, or combinations of variants, with
disease. Table 2 shows the frequency in cases and controls of each
of the identified SNPS, and figure 1 displays the pattern of
variation across the gene for both heterozygous and homozygous
individuals. There were no statistically significant differences
between the frequency of any individual SNP between cases and
controls in either cohort.
Haplotype analysis
To investigate whether individuals with combinations of TIRAP
SNPs might influence disease occurrence, we undertook analysis of
the frequency of combinations of two or more variants in cases and
controls. There were more combinations in the Xhosa group than
in the mixed ancestry group, which might be expected due to the
small size of the mixed ancestry cohort. However, despite the small
size of this group there were several combinations that were
present that were not detected in the Xhosa. There were no
statistically significant differences between cases and controls for
any of the 53 combinations of SNPs that we observed in either
ethnic group (table 3 and fig. 2)
Effect of TIRAP variants on Disease Phenotype
We went on to investigated the role of TIRAP variants in
relation to disease manifestations by comparing the frequency of
each variant in patients with pulmonary compared to disseminated
TB. No SNP showed any association with the combined
phenotype of extrapulmonary TB compared to pulmonary TB
in either ethnic group.
We further analysed 558CRT to see if this SNP was associated
with TBM. No association was seen in the Xhosa cohort as there
were only eight cases that had the heterozygous genotype and
none of these had TBM. However, comparing TBM to all other
Table 1. Sequence variants in TIRAP exons and 39
untranslated region in Xhosa and mixed ancestry populations.
SNP MAF Xhosa MAF Coloured p value
p25 G/C
a 0.04 0.02 NS
p164 G/A
a 0.05 0.02 NS
p298 G/A
ab 0.004 0.007 NS
p303 G/A 0.002 0 NA
p393 C/T
b 0.03 0.03 NS
p427 C/T
ab 0.004 0 NA
P539 C/T
a 0.002 0.04 ,0.001
P548 G/C
ab 0.009 0.01 NS
p558 C/T 0.03 0.13 ,0.001
p589 G/A
a 0.02 0.03 NS
P655 C/T
b 0.02 0.01 NS
p760 A/G
b 0.09 0.09 NS
p820 C/T 0.47 0.2 ,0.001
Minor allele frequency (MAF) of each SNP is shown in the Xhosa and Mixed
ancestry populations (Cases and controls combined). P values were calculated
by the Fishers exact test. Significant differences in MAF between the two
populations are seen at positions 539, 558 and 820.
aThese polymorphisms caused an amino acid change.
bThese polymorphisms are novel.
doi:10.1371/journal.pone.0006698.t001
No Association of TIRAP and TB
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of the heterozygous SNP was found (P,0.05, table 4). When we
compared TBM to the controls this SNP was still significantly
associated with disease (p=0.02). There were in total 29 patients
of mixed ancestry who had extrapulmonary TB. Of these, eight
had the CT genotype and 6 of these had TBM. The other two had
Pleural effusions and E. Nodosum.
Cytokine levels and genotype
In order to establish whether any of the SNPs were associated
with altered TLR signalling, as has been suggested in previous
studies [20], we evaluated LPS induced TNF production as a
marker of inflammatory gene induction through the TLR4
pathway from all controls and cases after they had cleared the
infection. Although none of the identified SNPs showed significant
Table 2. Frequency of TIRAP variants in cases and controls for Xhosa and Mixed ancestry groups.
SNP position Xhosa Mixed ancestry
(Amino acid change) Genotype Cases (%) Controls (%) p-value Cases (%) Controls (%) p-value
p25 CC 125 (93) 106 (89) 51 (94) 15 (100)
(A9P) CT 8(6) 12 (10) 0.3 3 (6) 0 0.6
TT 00 00
p164 GG 122 (0.91) 101 (89) 45 (89) 13 (100)
(S55N) GA 12 (9) 13 (11) 0.6 7 (11) 0 0.5
AA 0 1 (0.01) 1 0
p298 GG 142 (99) 121 (99) 53 (0.98) 16 (100)
(A100T) GA 1 (1) 1 (1) 1 1 (2) 0 1
AA 00 00
p303 GG 142 (99) 122 (100) 54 (100) 16 (100)
GA 1 (1) 0 1 0 0 NA
AA 00 00
p393 CC 135 (94) 112 (92) 50 (93) 16 (100)
CT 8 (6) 10 (8) 0.5 4 (7) 0 0.6
TT 00 00
p427 CC 143 (100) 120 (98) 50 (93) 16 (100)
(R143W) CT 0 2 (2) 0.2 0 0 NA
TT 00 00
p539 CC 142 (99) 122 (100) 51 (94) 14 (88)
(S180L) CT 1 (1) 0 1 3 (6) 1 (6) 0.3
TT 0 0 0 1 (6)
p548 GG 141 (99) 119 (98) 52 (96) 16 (100)
(R184T) GC 2 (1) 3 (2) 0.7 2 (4) 0 1
CC 00 00
p558 CC 135 (94) 114 (93) 41 (76) 13 (81)
CT 8 (6) 8 (7) 0.8 12 (22) 2 (13) 0.5
TT 0 0 1( 2 ) 1( 6 )
p589 GG 136 (95) 117 (96) 51 (94) 15 (0.94)
(V197I) GA 7 (5) 5 (4) 0.8 3 (6) 1 (0.06) 1
AA 00 00
p655 CC 138 (97) 118 (97) 52 (96) 16 (100)
CT 5 (3) 4 (3) 1 2 (4) 0 1
TT 00 00
p760 AA 116 (81) 102 (84) 44 (81) 14 (88)
AG 26 (18) 19 (16) 0.8 9 (17) 2 (13) 1
GG 1 (1) 1 (1) 1 (2) 0
p820 CC 29 (20) 40 (33) 0 0
CT 63 (44) 48 (39) 0.7 20 (37) 8 (50) 0.4
TT 50 (35) 34 (28) 34 (63) 8 (50)
The p-values for differences between cases and controls in each ethnic group were calculated by Fishers exact test or the Freeman Halton extension of the Fishers exact
test when all three genotypes were present. No significant differences in the frequency of any SNP or genotype was observed between cases and controls. Differences
in numbers of samples are due to sequence failures.
doi:10.1371/journal.pone.0006698.t002
No Association of TIRAP and TB
PLoS ONE | www.plosone.org 3 August 2009 | Volume 4 | Issue 8 | e6698Table 3. Frequency of SNP combinations in Xhosa and mixed ancestry groups.
Combination number Genotype Xhosa Mixed ancestry
Cases Controls Cases Controls
1 No SNP 0.17 0.26 0.13 0.33
2 25GC 0.02 0.06 * *
3 164GA 0.02 0.02 * *
4 820CT 0.27 0.17 0.19 0.25
5 820TT 0.11 0.06 * *
6 25GC+820CT 0.02 0.02 0.02 0.00
7 25GC+820TT 0.01 0.00 * *
8 164GA+820CT 0.03 0.08 * *
9 164GA+820TT 0.01 0.01 0.02 0.00
10 164AA+820TT 0.00 0.01 0.02 0.00
11 298GA+820CT 0.01 0.00 * *
12 298GA+820TT * * 0.02 0.00
13 393CT+760AG 0.00 0.01 * *
14 393CT+820CT 0.02 0.02 * *
15 393CT+820TT 0.01 0.05 0.04 0.00
16 539CT+820CT * * 0.02 0.00
17 539CT+820TT * * 0 0.08
18 548GC+820TT * * 0.02 0.00
19 551GC+820TT 0.01 0.00 * *
20 558CT+820CT 0.01 0.03 0.04 0.08
21 558CT+820TT 0.02 0.01 0.08 0.00
22 558TT+820TT * * 0.02 0.08
23 589GA+820CT 0.01 0.01 0 0.08
24 589GA+820TT 0.02 0.00 0.02 0.00
25 655CT+820CT 0.00 0.01 * *
26 655CT+820TT 0.02 0.00 * *
27 760AG+820CT 0.04 0.04 0.06 0.08
28 760AG+820TT 0.07 0.06 0.08 0.00
29 760GG+820TT 0.01 0.01 0.02 0.00
30 25GC+164GA+820TT 0.01 0.00 * *
31 25GC+539CT+820CT * * 0.02 0.00
32 25GC+558CT+820CT 0.00 0.01 * *
33 25GC+760AG+820CT 0.01 0.01 * *
34 164GA+298GA+820TT 0.00 0.01 * *
35 164GA+558CT+820TT 0.01 0.00 0.04 0.00
36 164GA+589GA+820TT * * 0.02 0.00
37 164GA+655CT+820TT * * 0.02 0.00
38 164GA+760AG+820CT 0.01 0.00 * *
39 164GA+760AG+820TT 0.02 0.00 0.02 0.00
40 303GA+539CT+820CT 0.01 0.00 * *
41 393CT+558CT+820TT 0.00 0.01 0.04 0.00
42 393CT+589GA+820TT 0.01 0.00 * *
43 393CT+655CT+820TT 0.01 0.00 * *
44 551GC+589GA+820TT 0.01 0.00 * *
45 548GC+589GA+820TT * * 0.02 0.00
46 558CT+589GA+820TT * * 0.02 0.00
47 558CT+760AG+820CT 0.00 0.01 * *
48 558CT+760AG+820TT 0.02 0.00 * *
49 589GA+760AG+820TT 0.01 0.01 * *
No Association of TIRAP and TB
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differences were seen in TNF production for two variants. In the
Xhosa group we found that individuals carrying a single copy of
the novel 548GRC (R184T) or the previously identified 589GRA
(V197I) SNP, showed significantly higher TNF production than
those with the wildtype (p,0.05) (fig. 3).
Discussion
TIRAP is a critical gene in the TLR2 and TLR4 signalling
cascades and recent studies have investigated its role in a number
of infectious diseases including TB. There have been conflicting
results from these papers, which may be due to ethnic differences
in the populations studied. In order to understand the architecture
of genetic variation across the gene, and its relationship to
childhood TB, we screened the entire open reading frame for
variation, rather than using only known variants. This approach
allowed us to detect novel polymorphisms, as well as identify any
disease-causing or rare mutations in either the control or disease
populations, but did not detect intronic or promoter variants
We compared two ethnic groups from Cape Town, South
Africa and showed that they have very different SNP patterns.
Some SNPs were seen in both groups while others differed
significantly in frequency. We identified several novel SNPs and
observed a larger number (13 SNPs) than was found in studies on a
Caucasian population (7 SNPs) [20] or a Vietnamese population (4
SNPs) [23]. Our data demonstrates the importance of identifying
the pattern of variation in any ethnic population rather than
relying only on previously reported frequencies of SNPs.
The 539CRT (S180L) has been shown to be protective against
TB in a West African cohort [20]. This was confirmed in a small
Columbian [21] study but was not reproduced in a joint
Ghanaian, Russian, and Indonesian study [22] nor in a
Vietnamese group [23]. This SNP was found at a frequency
higher than 0.05 in the UK Caucasian population [20] but in all
other studied populations, including ours, the frequency of the
SNP was very low (we found the heterozygous genotype in only
one case in the Xhosa group). The small sample size in our study is
a major limitation when screening for low frequency SNPs. The
539T allele was only present at a frequency of 0.002 in this
population and this may explain our inability to confirm the
association of this SNP with protection from TB reported in other
populations [21,20] . However, what we can conclude is that due
to its low frequency, any advantageous effect that this SNP confers
will be of very limited significance in the Xhosa population.
There were significantly more heterozygous individuals in the
mixed ancestry group compared to the Xhosa group but with the
small numbers in our study we could not show significant
association between genotype and disease. The high frequency of
the SNP in European groups compared to African populations may
be the consequence of selective pressure on TIRAP. However, in
view of the complex selective pressure of several infectious diseases
including TB, malaria, and bacterial sepsis, each of which may
select different variants in TLR signalling, speculation on the
reasons for ethnic variation in the genes controlling TLR signalling
should await further data on the association of these variants with
common childhood diseases in African and Caucasian populations.
Previous studies on a Vietnamese adult cohort have shown an
association of the 558CRT heterozygous SNP with TBM [23].
This SNP was at very low frequency in the Xhosa group; however,
in the mixed ancestry population the heterozygous variant was
significantly more common in the subgroup with TBM. Six out of
ten patients with TBM had the CT genotype whereas only one out
of nine children with Pleural effusion had the CT genotype. The
only other child to carry the CT genotype had E. Nodosum. These
numbers are too small to draw any firm conclusions but they do
suggest that the CT genotype may be associated with severer forms
of TB particularly TBM and are consistent with the finding in the
Vietnamese study.
The mixed ancestry group are a very heterogeneous population
with many having East Asian ancestry [26]. This may explain why
the SNP, which has been shown to affect TBM in Vietnamese, was
more prevalent in this group compared with the Xhosa. It is also
interesting to note that both the minor allele frequencies in SNP
539CRT and 558CRT were significantly different between the
two ethnic groups studied. This again highlights the need to
evaluate the whole gene when screening unstudied populations as
opposed to searching only for previously published SNPs.
The 558CRT SNP does not cause an amino acid base change
nor was it associated with altered TNF production in response to
LPS in our study. This confirms the findings from the Vietnamese
study that did not find an association with TNF production in
response to LPS, which signals through the TLR4. However, they
did find altered IL-6 production in response to lipopeptides, which
signals through TLR2. This suggests that any effect of this SNP on
TIRAP is specific to TLR2 signalling. The 558 SNP is however
synonymous and may not itself be the disease causing allele, but
may be in linkage disequilibrium with some other, unknown
variant which we were unable to identify in our study.
Alternatively the SNP may be having a function that we are
unable to identify with our assays. Synonymous mutations have
been shown to affect folding of mRNA secondary structures and
thereby protein expression [27,28] . Synonymous SNPs that occur
close to the intron exon junctions can also disrupt the splicing
process [29,30], although this is unlikely to be the case with the
558 SNP as it is well within the exonic region. Although many
non-coding SNPs have now been described that are associated
with disease (for a list of diseases see [31]) the mechanism by which
this SNP is associated with TBM at present remains unknown.
Combination number Genotype Xhosa Mixed ancestry
Cases Controls Cases Controls
50 655CT+760AG+820CT 0.01 0.01 * *
51 25GC+551GC+589GA+820CT 0.00 0.01 * *
52 164GA+655CT+760AG+820TT * * 0.02 0.00
53 551GC+589GA+655CT+820TT 0.00 0.01 * *
*Combination not present.
doi:10.1371/journal.pone.0006698.t003
Table 3. Cont.
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589GRA (V197I), compared to the homozygous wildtype, were
both associated with higher levels of TNF production in the Xhosa
group. Neither of these SNPs was significantly more frequent in
cases than controls suggesting that the increase in TNF in these
individuals was not due to their having had TB. We measured TNF
production in response to LPS stimulation, which actsvia the TLR4
receptor [32,33]. TLR2 rather than TLR4 is the predominant
receptor triggered by TB [15], however, both receptors follow a
similar signal transduction pathway requiring TIRAP. Individual
polymorphisms in TIRAP may affect signalling of each of the TLRs
differently and so the increase in TNF production following LPS
stimulationmayonlyberelevanttoTLR4and maynotaffectTLR2
signalling inthesame way. Thesefunctional assayswould havebeen
better carried out using a TLR2 agonist or stimulant. At the time of
enrolment to our study M.Tb was thought to activate both the
TLR2 and TLR4 pathways [13], and as the functional assay using
LPS was used to probe interferon gamma responses, and both
TLR2 and TLR4 followed the same pathway downstream of
TIRAP, it was reasoned that LPS stimulation would be sufficient to
demonstrate the function of TIRAP in TB. Since then it has been
shown that it is TLR2 that is directly involved with TB immunity
[15], and it may have been preferable to use both TLR2 and TLR4
agonists to explore the role of TIRAP.
Figure 1. Sequence variation in TIRAP in the Mixed ancestry and Xhosa cases and controls. Representation of the opening reading frame
of the TIRAP gene with the frequency of SNPs in the A) Mixed ancestry group and in the B) Xhosa group at various positions in the gene. Red blocks
represent the coding region and the yellow blocks the 39 UTR. Bold numbers and letters show published SNPs. Heterozygous SNPs with position in
the gene are shown above the gene diagram; homozygous SNPs with base change and amino acid change (if nonsynonymous) shown below the
gene diagram.
doi:10.1371/journal.pone.0006698.g001
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kept the Xhosa and the mixed ancestry cohorts separate
throughout this study. This resulted in small numbers in the
individual cohorts, particularly in the mixed ancestry group. Large
numbers are required to demonstrate moderate effects of low
frequency SNPs. While the low numbers of the 539CRT SNP in
the Xhosa population makes it difficult to draw definite
conclusions on the role of this variant, our data may in future
be used in meta-analysis in combination with other childhood
cohorts to confirm the association
The mixed ancestry population are an admixed group and very
large numbers of samples would be required to eliminate ‘‘ethnic
specific’’ confounders and to be able to draw significant conclusions.
Despite the small numbers the significant association of the 558
SNP with TBM is in keeping with the Vietnamese study and is thus
likely to represent a genuine effect.
Ourworkisthe first studytoinvestigate the roleofpolymorphisms
in the TIRAP gene in a paediatric cohort. Our results suggest that
polymorphic variation in this gene is not involved in susceptibility to
TBinXhosachildrenorthoseofmixedancestryinSouthAfrica,but
may affect the likelihood of developing TBM. This is particularly
interesting as children are more likely to develop TBM than adults
Further work on the relevance of this gene in a larger cohort would
therefore be beneficial. Furthermore the markedly different SNP
pattern in the two ethnic groups highlights the importance of
identifying SNPs present in different ethnic populations first, rather
than utilising only published variants from case control studies,
before drawing conclusions about disease association
Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Research Ethics Committee, University of Cape Town and St.
Mary’s London (LREC: 01/GB/218E; Reference number: 013/
2000). All patients provided written informed consent for the
collection of samples and subsequent analysis.
Figure 2. Combinations of SNPs in TIRAP found in individual patients or controls. Graph shows the frequency of 53 SNP combinations
found in the A) Mixed ancestry and B) Xhosa groups. The blue bars are the cases and the orange bars are the controls. No combination of SNP was
statistically significant between cases and controls when analysed by Fishers exact test.
doi:10.1371/journal.pone.0006698.g002
No Association of TIRAP and TB
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Children of Xhosa origin and mixed ancestry were recruited at
Red Cross Children’s hospital in Cape Town, South Africa. The
Xhosa are an indigenous black population of South Africa and
speak the Xhosa language. Those of mixed ancestry are from the
group commonly referred to in South Africa as Coloureds. These
people are from a mix of several racial ancestries from Europe,
Indonesia, Madagascar and from across Southern Africa. The
Cape Coloureds make up the predominant population group in
the Western Cape and are of Malay origin mixed with either
European or the indigenous Khoi and San people. They are
referred to throughout the paper as mixed ancestry.
Casesweredrawnfromtwostudies,oneofacute newlydiagnosed
TB, and one of patients previously treated for TB (Past history
cases). Acute cases were recruited at the time of admission and the
commencement of anti-TB chemotherapy, while past history cases
were enrolled at least one year after their initial diagnosis. They
were identified via the hospital and microbiology departmental
records of The Red Cross Children’s Hospital, Cape Town. In the
Xhosa group 83 children were enrolled as acute cases and 59 were
enrolled as past history cases. In the mixed ancestry group 42 were
acute cases and 12 were past history cases. Cases were categorised
according to the certainty of their TB diagnosis. Those categorised
as definite TB had a diagnosis confirmed by culture of Mycobacterium
tuberculosis (M. tb) from sputum, gastric aspirate, CSF or other body
fluids or biopsy material (Xhosa n=44; Mixed ancestry n=14).
Highly Probable TB had Acid Fast Bacilli (AFB) identified in
sputum, gastric aspirate, CSF, other body fluids or on histological
examination of biopsy material but with no culture confirmation
having been obtained. (Xhosa n=8). Probable TB was diagnosed
according to World Health Organisation (WHO) criteria for
suspecting TB in children (Xhosa n=90, Mixed ancestry n=40).
The clinical records, and microbiological results of all patients were
reviewed by two paediatricians with experience of childhood TB,
and only those in whom the findings and response to treatment was
consistent with TB were retained in the study.. Children over 14
years of age, HIV seropositive or with other underlying immuno-
deficiency or those that had been on prolonged treatment with
steroids or other immuno-suppressive drugs were excluded from the
study.
Neighbourhood, age matched controls comprised of 122 Xhosa
children and 16 of mixed ancestry. These controls were living
within three streets of, and were unrelated to a case. Mantoux skin
testing for evidence of infection with M. tb was carried out by one
nurse, using 2 tuberculin units of purified protein derivative RT-23
[Statens Serum Institut, Copenhagen, Denmark]. Controls were
categorised as Mantoux positive if they had an induration
diameter of $10 mm. Any child with an induration diameter of
15 mm or greater was referred to the local TB clinic for chest x-
ray and assessment in accordance with national guidelines and
excluded from analysis if diagnosed with TB. Clinical data was
obtained for all patients and blood collected for functional assays
and DNA extraction.
All subjects in the study lived in townships in Cape Town both in
formaland informalhousing.Thesetownships areverycrowdedand
over two thirds of the controls and 70% of cases had been in contact
with someone with TB, often a household member.
Table 4. Genotype at position 558 of TIRAP and disease
phenotype in the mixed ancestry cohort.
CC CT TT Total
Pulmonary 21 3 1 25
Extrapulmonary 20 8 0 28
Total 41 11 1 53 NS
TBM 4601 0
No TBM 37 5 1 43
Total 41 11 1 53 p,0.05
TBM 4601 0
Controls 13 2 1 16
Total 17 8 1 26 p=0.02
Numbers of patients with mixed ancestry who had extrapulmonary TB
compared to those that had pulmonary TB (top panel) and patients that had
TBM compared with those that had other forms of TB (middle panel) for each
genotype at position 558 of TIRAP. The lower panel shows the number of TBM
patients compared with the healthy controls.
doi:10.1371/journal.pone.0006698.t004
Figure 3. TNF induction in response to LPS in individuals with TIRAP variants. Graph shows the average TNF production in response to
stimulation of whole blood with LPS from three separate experiments in Xhosa individuals with variant genotypes at positions 548 and 589 of the
TIRAP gene. The error bars show the median with 95% confidence interval.
doi:10.1371/journal.pone.0006698.g003
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that a control could become a case in future. All controls and past
history cases were therefore seen again one month and 6 months
after their initial visit to confirm that their status had not changed.
Functional studies to measure TNF upregulation in whole
blood
Blood from all study subjects was collected at recruitment and
on up to three consecutive visits (Admission, 6 months and 1 year
for acute cases, and enrolment, one month and six months for all
others). For the assessment of TNF responses, only data obtained
at least 6 months after commencing anti TB treatment was utilised
Blood was collected into preservative-free heparin tubes was
diluted 1:10 in RPMI 1640 (supplemented with penicillin and
streptomycin and L-glutamine). A round bottomed 96 well plate
containing 180 ml of the diluted blood was set up to include 4
different experimental conditions. These included wells with
media only or with 0.5 ng/ml. The LPS was added only after
the cells had been allowed to incubate for two hours at 37uCi na
5% CO2 humidified incubator. Each condition was carried out in
quadruplicate and plates incubated overnight. Supernatants were
harvested after 24 hours and the concentration of TNF deter-
mined by standard ELISA methods. All cytokine assays were
carried out on the day that the blood was collected.
Amplification of the TIRAP open reading frame and 39
untranslated region by PCR
Primers spanning the two coding exons of TIRAP were
synthesized by Sigma genosys (Haverhill, UK). Exon 1 primers
were as previously published [23]. For mutation detection gel
analysis (MDGA) optimal product size was 300 bp so PCR
amplification of exon 2 was split into 2 regions. Exon 2i was
analysed by MDGA using the forward primer CTCTGAGAA-
TAAGATGTTTCC and the reverse primer ACGCAGACGT-
CATAGTCTTT. Exon 2ii had too many SNPs to be detected by
this method and was analysed by direct sequencing. The 2ii
forward primer was AGTGACAGTGGCAGTAGTC and 2ii
reverse primer was CCTGTTGGTCAGTGAGGAAA. Primers
were designed with both 39 Fam labelling for use in MDGA and
without any label for sequencing. Standard PCR reactions were
carried out using 1.5 mg/ml MgCl2 and an annealing temperature
of 59uC for exon 1 and 2i and 64uC for exon 2ii.
Mutation Detection Gel Analysis (MDGA)
MDGA is a high throughput method which combines single
stranded conformational polymorphism (SSCP) and heterduplex
mutation analysis (HMA) to identify sequence changes by shift in
the electrophoretic migration of the DNA [34] The entire cohorts
of patients and controls were screened for sequence variation, with
any band shifts being confirmed by sequencing.
One microlitre of the PCR product was added to 3 mlo fR o x
500XL (Applied Biosystems, Warrington, UK) and Elliomut loading
buffer (Ellios biotek Laboratory, Paris, France), denatured at 96uC
for 2 minutes and cooled immediately on ice. Samples were then
loaded onto 36 cm Elliomut gels (Ellios biotek Laboratory, France)
using 96 well CAM combs and run for 3.5 hr on the recommended
manufacturers programme for MDGA. The Elliomut gel is a
specially formulated non-denaturing polyacrylamide gel that allows
the separation of single stranded DNA by conformational changes
and also analysis of the heteroduplex. Samples were analysed using
the ABI 377 using Genescan and Genotyper programmes. All
bandshifts and pattern changes (i.e. migration profiles) were
recorded. Random samples showing different bandshifts were
PCR amplified with unlabelled primers, cleaned, cycle sequenced
and then run on a capillary sequencer at the University of Oxford,
Department of Zoology sequencing facility.
Statistical Analysis
Differences between cases and controls for each detected SNP
and between combinations of SNPs were investigated by Fishers
exact test using Graphpad prism.
Data plotted for TNF production for each individual was the
average result of functional assays performed on the six and 12
month visit for acute cases, and the average of three visits for the
past history cases and controls. Differences in TNF production
between different genotypes was analysed by the Mann Whitney t
test where only two genotypes were present, or the Kruskall Wallis
ANOVA when all three genotypes were identified.
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